FERNDALE, Mich. and NEW YORK, Aug. 14 Biopelle, Inc., a Ferndale Pharma Group company announced today the acquisition of PRESCRIBEDsolutions [CUSTOMIZED SKINCARE]. Since its launch in 2004, PRESCRIBEDsolutions has gained acceptance among top dermatologists and plastic surgeons with its innovative, customizable skincare line. Among its acclaimed products are the DNA repair product Stop the Clock(TM) Triple Action Anti-aging Day Cream SPF 50, Control Tactics(TM) Neurocosmetic Soothing Gel and Body of Knowledge(TM), a clinically proven Slimming & Contouring Cream. The Biopelle, Inc. subsidiary of the Ferndale Pharma Group was specially formed to provide groundbreaking technologies, such as AFA's acidified amino acids and Tensage's SCA Biorepair growth factors, to the medical community. The joining of PRESCRIBEDsolutions and Biopelle creates a unique company with a global spectrum of innovative medically-based skincare products.
"We chose Biopelle because its sales organization and strong brands provide the appropriate platform to accelerate the growth of PRESCRIBEDsolutions's success to date. With its background and connection to Ferndale Laboratories, a well respected pharmaceutical company for over a century, Biopelle has the reach in the aesthetic medical community that will benefit these unique, customizable products," Aurelian Lis, President and COO of PRESCRIBEDsolutions, said in a statement.
PRESCRIBEDsolutions and Biopelle have complementary products that not only offer relief for the patient, but also visible results and immediate protection. For example, PRESCRIBEDsolutions' Control Tactics Neurocosmetic Soothing Gel and Up the Anti(TM) Sunscreen are a perfect match to Biopelle's topical anesthetic, L.M.X.4(R) and anti-bruising Auriderm Post Op Gel. The four products together provide the optimal pre and post-aesthetic procedure regimen.
Elliott Milstein, President of Biopelle said, "The addition of PRESCRIBEDsolutions [CUSTOMIZED SKINCARE] to the Biopelle portfolio is consistent with our operating philosophy of offering physicians breakthrough skincare products. It represents everything on which we have built our current business -- innovation, exceptional quality and true value to the consumer."
"The PRESCRIBEDsolutions brand fits with our brands as a stand-alone, innovative system of skincare, as well as providing individual unique products within the line that Biopelle had been lacking. The addition of PRESCRIBEDsolutions completes Biopelle's goal of becoming a one-stop-shop for the dispensing aesthetic physician," Milstein added.
Biopelle, Inc. is the aesthetic subsidiary of the Ferndale Pharma Group (FPG) - a company built on the lasting commitment to and understanding of dermatology. FPG has served the medical community since 1897. In 2005 Biopelle was established and charged with the task of developing a unique product portfolio for the aesthetic medical professional. Biopelle began with two brands, LMX and OCEight(TM), and has added five additional brands, AFA(R), Auriderm(R), Ascorderm(R), Retriderm(R) and Tensage(R). Biopelle continues to add new products and brands, like PRESCRIBEDsolutions, that are unique, effective and represent cutting edge technology.
PRESCRIBEDsolutions was founded by Aurelian Lis and David May, two former cosmetics industry executives. Their unique, patent-pending customization process has proven to be a strong competitive edge with high consumer acceptance. The line is currently distributed in the offices of some of the most highly regarded dermatologists in the United States.
PRESCRIBEDsolutions is the only skincare line that enables physicians to use their professional knowledge to customize skincare products. During the consultation, the physician examines the patient's skin to determine their dermatological needs. An appropriate booster is selected and each product is customized. As the patient's needs change over time, the physician adjusts the products and boosters accordingly. PRESCRIBEDsolutions products address the main aesthetic and anti-aging skincare concerns of patients visiting dermatologists.
This new entity will be a powerhouse of innovation for the aesthetic medical community.
Note to Editor: Lis and Milstein are available for interviews. Aurelian Lis: (917) 496-8888 Elliott Milstein: (248) 586-8554 Images available
SOURCE Biopelle, Inc.